OncoSec Medical Inc ONCSQ

Healthcare Biotechnology

OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method that enables transient expression of recombinant therapeutic molecules in cells. The OMS EP Device is designed to promote cellular uptake of plasmid DNA injected directly into solid tumors to allow subsequent expression of the encoded therapeutic protein. The OMS EP Device can be adapted to treat different tumor types and consists of an electrical pulse generator and a disposable applicator. Its lead product candidate, tavokinogene telseplasmid (TAVO), is a plasmid encoding human interleukin-12.

GREY:ONCSQ - Post by User

OncoSec Medical Inc

Bullboard Posts

Post by marison Dec 22, 2014 10:26am

313 Views

Post# 23255655

this was a pump job

the smallest fish were brought in witht he promise of secret news and a sure fire money maker. I mean how small? Guys who have never played the market so were taken by the hush hush guaranteed success in the future

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading